Product Images Nylia 1/35

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Nylia 1/35 NDC 65862-898 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure1 - norethindroneethinyl fig1

Figure1 - norethindroneethinyl fig1

The text describes a figure depicting circulatory disease mortality rates by age, smoking status and oral contraceptive use. The figure shows mortality rates per 100,000 women-years and includes groups of smokers and non-smokers who have ever used oral contraceptives and controls who have not. The mortality rates vary by age group, with higher rates for older women. The source reference of the figure is mentioned.*

Elliona Figure 2 - norethindroneethinyl fig2

Elliona Figure 2 - norethindroneethinyl fig2

This text provides a list of studies conducted on women's use of contraceptives, including their current or past use, and the associated effect estimate. The studies mentioned are the NICHD Women's Contraceptive Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses' Health Study I, xord Family Planning Association Study, The Nurses' Health Study II, and Danish Sex Hormone Register Study. The effect estimate (OR/RR) is given for each study, and some of them include the years the studies were conducted. The last line of numbers is not clear and its purpose is not evident.*

Elliona Figure 3 - norethindroneethinyl fig3

Elliona Figure 3 - norethindroneethinyl fig3

Elliona Figure 4 - norethindroneethinyl fig4

Elliona Figure 4 - norethindroneethinyl fig4

This is a label template for selecting the correct day of the week. There is an example image with encrypted text in it. The last line refers to a medication named Nylia containing 1 mg of Norethindrone and 0.035 mg of Ethinyl Estradiol in tablet form.*

Elliona Figure 5 - norethindroneethinyl fig5

Elliona Figure 5 - norethindroneethinyl fig5

Elliona Figure 6 - norethindroneethinyl fig6

Elliona Figure 6 - norethindroneethinyl fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 1 mg/0.035 mg Pouch Label - norethindroneethinyl fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 1 mg/0.035 mg Pouch Label - norethindroneethinyl fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 1 mg/0.035 mg Pouch Carton - norethindroneethinyl fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 1 mg/0.035 mg Pouch Carton - norethindroneethinyl fig8

norethindroneethinyl fig9

norethindroneethinyl fig9

This is a product description for Nylia™ 1/35 which is a combined oral contraceptive containing Norethindrone and Ethinyl Estradiol Tablets, USP. It is intended for the prevention of pregnancy but does not protect against sexually transmitted diseases. The usual dosage is one tablet daily as prescribed, and the product comes with six pouches with each containing 28 tablets. The product is distributed by Aurobindo Pharma USA, Inc. and made in India. It is important to keep it out of reach of children. The text also includes information about the contents of each tablet and storage conditions.*

Chemical Structure - norethindroneethinyl str

Chemical Structure - norethindroneethinyl str

Norethindrone Ethinyl estradiol is a pharmaceutical product composed of chemicals OH, CHy, CHy, C=CH, o", and HO. No further information about this substance is available from the given text.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.